BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28732670)

  • 1. Long non-coding RNA NEAT1 overexpression is associated with unfavorable prognosis in patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study.
    Liu Z; Chang Q; Yang F; Liu B; Yao HW; Bai ZG; Pu CS; Ma XM; Yang Y; Wang TT; Guo W; Zhou XN; Zhang ZT
    Eur J Surg Oncol; 2017 Sep; 43(9):1697-1703. PubMed ID: 28732670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic values of long non-coding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomy.
    Dong Y; Yan W; Zhang SL; Zhang MZ; Zhou YP; Ling HH; Ning M; Zhao Y; Huang A; Zhang P
    Oncotarget; 2017 Dec; 8(69):114041-114049. PubMed ID: 29371967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long non-coding RNA AK001796 contributes to poor prognosis and tumor progression in hepatocellular carcinoma.
    Han QL; Chen BT; Zhang KJ; Xia ST; Zhong WW; Zhao ZM
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2013-2019. PubMed ID: 30915744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEAT1 promotes cell proliferation and invasion in hepatocellular carcinoma by negative regulating miR-613 expression.
    Wang Z; Zou Q; Song M; Chen J
    Biomed Pharmacother; 2017 Oct; 94():612-618. PubMed ID: 28783584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma.
    Zhou T; Gao Y
    World J Surg Oncol; 2016 Jan; 14(1):8. PubMed ID: 26758762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
    Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
    Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients.
    Guo S; Chen W; Luo Y; Ren F; Zhong T; Rong M; Dang Y; Feng Z; Chen G
    Int J Clin Exp Pathol; 2015; 8(5):5395-402. PubMed ID: 26191242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3.
    Zhang XN; Zhou J; Lu XJ
    J Cell Physiol; 2018 Sep; 233(9):6733-6741. PubMed ID: 29219178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-2α activated lncRNA NEAT1 promotes hepatocellular carcinoma cell invasion and metastasis by affecting the epithelial-mesenchymal transition.
    Zheng X; Zhang Y; Liu Y; Fang L; Li L; Sun J; Pan Z; Xin W; Huang P
    J Cell Biochem; 2018 Apr; 119(4):3247-3256. PubMed ID: 29091312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA NEAT1 is an unfavorable prognostic factor and regulates migration and invasion in gastric cancer.
    Fu JW; Kong Y; Sun X
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1571-9. PubMed ID: 27095450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma.
    Hua L; Wang CY; Yao KH; Chen JT; Zhang JJ; Ma WL
    Int J Clin Exp Pathol; 2015; 8(3):3076-82. PubMed ID: 26045820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA.
    Pan Y; Qin T; Yin S; Zhang X; Gao X; Mu L
    Biomed Pharmacother; 2017 Mar; 87():669-677. PubMed ID: 28088733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA NEAT1 Promotes Deterioration of Hepatocellular Carcinoma Based on In Vitro Experiments, Data Mining, and RT-qPCR Analysis.
    Ling ZA; Xiong DD; Meng RM; Cen JM; Zhao N; Chen G; Li RL; Dang YW
    Cell Physiol Biochem; 2018; 48(2):540-555. PubMed ID: 30021196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival.
    Kessler SM; Hosseini K; Hussein UK; Kim KM; List M; Schultheiß CS; Schulz MH; Laggai S; Jang KY; Kiemer AK
    Cell Physiol Biochem; 2019; 52(4):787-801. PubMed ID: 30946555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy.
    Yuan SX; Yang F; Yang Y; Tao QF; Zhang J; Huang G; Yang Y; Wang RY; Yang S; Huo XS; Zhang L; Wang F; Sun SH; Zhou WP
    Hepatology; 2012 Dec; 56(6):2231-41. PubMed ID: 22706893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of LncRNA SRA1 in hepatocellular carcinoma and its clinical significance.
    Luo P; Jing W; Zhu M; Li ND; Zhou H; Yu MX; Liang CZ; Tu JC
    Cancer Biomark; 2017; 18(3):285-290. PubMed ID: 28085012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.